Table 2 Main clinical features related to the surgical diagnoses
From: Impact of COVID-19 on urgent gastrointestinal surgery outcomes: increased mortality in 2020
Appendicitis (n = 1121) | Peritonitis and intra-abdominal infections (n = 888) | Occlusion (n = 713) | Parietal hernias (n = 323) | Anal and perianal diseases (n = 277) | Malignant digestive tumors (n = 134) | Sigmoid and inflammatory bowel diseases (n = 101) | Gastro-duodenal ulcer (n = 93) | Vascular intestinal diseases (n = 69) | Haemoperitoneum and digestive haemorrhage (n = 56) | |
|---|---|---|---|---|---|---|---|---|---|---|
Age, years, median [IQR] | 33[26–47] | 48[31–65] | 67[51–81] | 66[49–80] | 39[30–54] | 71[60–81] | 61[40–76] | 57[45–66] | 75[59–80] | 61[37–73] |
Charlson Score, median [IQR] | 0[0–1] | 2[0–5] | 52–7] | 4[2–6] | 1[0–3] | 9[6–12] | 3[1–6] | 4[2–6] | 7[5–8] | 4[0–8] |
Male gender, n (%) | 628(56) | 511(58) | 322(45) | 173(54) | 185(67) | 77(57) | 60(59) | 68(73) | 33(48) | 56 |
SARS-CoV-2 positive, n (%) | 25(2) | 31(3) | 23(3) | 12(4) | 11(4) | 7(5) | 3(3) | 6(6) | 3(4) | 4(7) |
LOS, days, median [IQR] | 2[1–4] | 6[3–13] | 7[4–14] | 4[2–7] | 2[1–4] | 18[9–30] | 15[10–24] | 9[6–18] | 15[5–34] | 10[3–26] |
ICU admission, n (%) | 10(1) | 160(18) | 118(17) | 28(9) | 12(4) | 40(30) | 28(28) | 31(33) | 45(65) | 28(50) |
Subsequent surgery, n (%) | 9(1) | 57(6) | 34(5) | 10(3) | 26(9) | 8(6) | 26(26) | 3(3) | 14(20) | 3(5) |
Subsequent hospital stay, n (%) | 86(8) | 152(17) | 139(19) | 49(15) | 41(15) | 45(34) | 40(40) | 12(13) | 22(32) | 8(14) |
Death, n (%) | 2(0) | 66(7) | 64(9) | 16(5) | 4(1) | 23(17) | 8(8) | 11(12) | 28(41) | 8(14) |
Post-operative complications | ||||||||||
Acute renal failure, n (%) | 5(0) | 95(11) | 71(10) | 17(5) | 4(1) | 23(17) | 10(10) | 18(19) | 31(45) | 8(14) |
Acute respiratory failure, n (%) | 4(0) | 73(8) | 50(7) | 9(3) | 3(1) | 12(9) | 11(11) | 13(14) | 18(26) | 8(14) |
Bacterial pneumonia, n (%) | 2(0) | 31(3) | 21(3) | 7(2) | 2(1) | 8(6) | 4(4) | 7(8) | 11(16) | 9(16) |
Aspiration pneumonia, n (%) | 1(0) | 18(2) | 46(6) | 8(2) | 1(0) | 9(7) | 2(2) | 2(2) | 5(7) | 1(2) |
Acute hepatic failure, n (%) | 1(0) | 10(1) | 8(1) | 2(1) | 4(3) | 2(2) | 2(2) | 7(10) | 1(2) | |
Pulmonary embolism, n (%) | 1(0) | 14(2) | 5(1) | 3(1) | 4(3) | 1(1) | 3(3) | 1(1) | 2(4) | |
Study period | ||||||||||
2018, n (%) | 224(20) | 193(22) | 134(19) | 64(20) | 68(25) | 22(16) | 20(20) | 23(25) | 14(20) | 12(21) |
2019, n (%) | 277(25) | 243(27) | 143(20) | 62(19) | 71(26) | 25(19) | 27(27) | 20(22) | 13(19) | 9(16) |
2020, n (%) | 161(14) | 109(12) | 112(16) | 42(13) | 38(14) | 24(18) | 12(12) | 11(12) | 15(22) | 16(29) |
2021, n (%) | 208(19) | 168(19) | 159(22) | 89(28) | 41(15) | 31(23) | 20(20) | 21(23) | 14(20) | 9(16) |
2022, n (%) | 251(22) | 175(20) | 165(23) | 66(20) | 59(21) | 32(24) | 22(22) | 18(19) | 13(19) | 10(18) |